what is glp 1 ras GLP-1 RAs: WHO endorse weight loss drugs for obesity control GLP-1R agonists: Full of hope,

A 32-year-old woman with no prior thyroid history developed painless biphasic thyroiditis (initial hyperthyroidism followed by temporary hypothyroidism) after two months of tirzepatide therapy

Individual results depend on genetics, adherence, diet quality, and physical activity

Stopping Treatment Appetite may increase, leading to weight regain

As GLP-1 therapy lightens the load: Joint Pain Often Fades: Walking, climbing stairs, or exercising becomes more comfortable, encouraging even more activity

These early touchpoints help set realistic expectations and keep patients from feeling caught off guard later

Article 4A